Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Oncotarget|April 20, 2013
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanismsMark Axelrod, Vicki L Gordon, Mark Conaway, et al.
Molecular Cancer Therapeutics|September 11, 2012
Synthetic lethal screening with small-molecule inhibitors provides a pathway to rational combination therapies for melanomaDevin G Roller, Mark Axelrod, Brian J Capaldo, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 2009
SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cellsSanna Kaikkonen, Tiina Jääskeläinen, Ulla Karvonen, et al.
The Journal of Biological Chemistry|February 14, 2008
Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitroLeonard C Shank, Joshua B Kelley, Daniel Gioeli, et al.
Cancer Research|November 18, 2015
Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell GrowthHuy Q Ta, Melissa L Ivey, Henry F Frierson, et al.
Molecular Endocrinology (Baltimore, Md.)|December 20, 2003
Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactionsBen E Black, Michael J Vitto, Daniel Gioeli, et al.
Biomacromolecules|August 1, 2007
Ruthenium(II) tris(bipyridine)-centered poly(ethylenimine) for gene deliveryGina L Fiore, James M Edwards, Sarah J Payne, et al.
Cancer Research|April 23, 2011
MST1 is a multifunctional caspase-independent inhibitor of androgenic signalingBekir Cinar, Filiz Kisaayak Collak, Delia Lopez, et al.
Pageof 9